To our knowledge, this is the first study to explore the association between a comprehensive panel of polymorphisms in the TGF-β pathway genes and bladder cancer risk and to identify subgroups that would be more likely to have higher cancer risk. The gene discussed is TGFB1; the disease is cancer.